These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11718438)

  • 1. Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution.
    Mukherjee D; Nissen SE; Topol EJ
    Cleve Clin J Med; 2001 Nov; 68(11):963-4. PubMed ID: 11718438
    [No Abstract]   [Full Text] [Related]  

  • 2. Cox-2 inhibitors and cardiovascular risk: the data are inconclusive, and these drugs are needed.
    Lipani J
    Cleve Clin J Med; 2001 Nov; 68(11):961-2. PubMed ID: 11718437
    [No Abstract]   [Full Text] [Related]  

  • 3. Cox-2 inhibitors and cardiovascular risk: point and counterpoint.
    Mandell BF
    Cleve Clin J Med; 2001 Nov; 68(11):957-60. PubMed ID: 11718436
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular ffects of COX-2 selective anti-inflammatory agents].
    Halinen MO
    Duodecim; 2001; 117(24):2570-1. PubMed ID: 12183817
    [No Abstract]   [Full Text] [Related]  

  • 5. Why do COX-2 inhibitors increase risk of cardiovascular events?
    Frankish H
    Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978344
    [No Abstract]   [Full Text] [Related]  

  • 6. MI risk prompts rofecoxib withdrawal.
    Thompson CA
    Am J Health Syst Pharm; 2004 Nov; 61(21):2234-6, 2238. PubMed ID: 15552625
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular events and COX-2 inhibitors.
    Minic M
    JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735746
    [No Abstract]   [Full Text] [Related]  

  • 8. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomedicine. Back to an aspirin a day?
    Vane JR
    Science; 2002 Apr; 296(5567):474-5. PubMed ID: 11964462
    [No Abstract]   [Full Text] [Related]  

  • 10. COX 2 inhibitors may increase risk of heart attack.
    Gottlieb S
    BMJ; 2001 Sep; 323(7311):471. PubMed ID: 11532833
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events.
    Mukherjee D
    Biochem Pharmacol; 2002 Mar; 63(5):817-21. PubMed ID: 11911832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular events and COX-2 inhibitors.
    Burnakis TG
    JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735741
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclooxygenase 2 inhibitors.
    Kelley KW; Ramsey LA
    Adv Nurse Pract; 2003 Mar; 11(3):22-4. PubMed ID: 12683165
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Kim JA; Choi YS; Yoon D; Cho KH
    Ann Intern Med; 2005 Oct; 143(8):615-6; author reply 617-8. PubMed ID: 16230734
    [No Abstract]   [Full Text] [Related]  

  • 15. COX-2 inhibitors: balancing the hope, the hype, and the concern.
    Mandell BF
    Cleve Clin J Med; 2001 Nov; 68(11):899. PubMed ID: 11718429
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Shinmura K; Bolli R
    Ann Intern Med; 2005 Oct; 143(8):617; author reply 617-8. PubMed ID: 16230737
    [No Abstract]   [Full Text] [Related]  

  • 17. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Pijak MR; Huzicka I; Gazdik F
    Ann Intern Med; 2005 Oct; 143(8):616-7; author reply 617-8. PubMed ID: 16230736
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclooxygenase inhibition: between the devil and the deep blue sea.
    Hawkey CJ
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III25-30. PubMed ID: 11953329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COX-2 specific inhibitors are similar--and different].
    Aly A
    Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular events and COX-2 inhibitors.
    Grant KD
    JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.